Literature DB >> 31267848

Prevalence of nasopharyngeal carriage of Streptococcus pneumoniae in children 7 to 14 years in 2016: A survey before pneumococcal conjugate vaccine introduction in Iran.

Manoochehr Karami1,2, Seyed Mehdi Hosseini3, Seyyed Hamid Hashemi2, Sima Ghiasvand4, Omid Zarei4, Nasim Safari4, Hossein Erfani5, Mohammad Yousef Alikhani2,4.   

Abstract

Streptococcus pneumoniae is a common cause of community-acquired pneumonia, meningitis, and otitis media in children. The aim of this study was to determine the prevalence of nasopharyngeal carriage of Streptococcus pneumoniae among children in the city of Hamadan, west of Iran. In this cross-sectional study, 532 students aged 7 to 14 years old from Hamadan were enrolled during the period from February to April 2016. Children were recruited using multi-stage sampling method. Informed consent form was obtained from parents of children. A researcher developed checklist was completed for every child by interviewer and samples of the throat of children were taken by swap method from the nasopharyngeal area. Descriptive statistics and chi square test were used to describe the study population. This study was approved by the Committee on Ethics of Hamadan University of Medical Sciences (IR.UMSHA.REC.1394.66). Prevalence of nasopharyngeal carriage of S. pneumoniae in children was 12.03% (95%CI: 9.38-15.10). About 37% (196 persons) of study population were male and 63% were female. Sixty four percent (345 people) of the studied population were from district two in Hamadan and others from District one. Prevalence of nasopharyngeal carriage of S. pneumoniae by sex was 13.77% (95% CI: 9.27-19.40) in males and 11.02 % (95% CI: 7.87-14.85) in females (P = 0.345). Considering the high prevalence of nasopharyngeal carriage of Streptococcus pneumoniae in children studied in Hamadan, pneumococcal conjugate vaccine (PCV) is recommended to be integrated into the Iran's National Immunization Program.

Entities:  

Keywords:  Iran; children; epidemiology; pneumococcal conjugate vaccine; prevalence

Mesh:

Substances:

Year:  2019        PMID: 31267848      PMCID: PMC6773412          DOI: 10.1080/21645515.2018.1539601

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  16 in total

Review 1.  Clinical and economic burden of community-acquired pneumonia among adults in Europe.

Authors:  T Welte; A Torres; D Nathwani
Journal:  Thorax       Date:  2010-08-20       Impact factor: 9.139

2.  Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW).

Authors:  Daniel Genné; Hans H Siegrist; Reto Lienhard
Journal:  Int J Infect Dis       Date:  2005-11-10       Impact factor: 3.623

3.  Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype.

Authors:  Juan J Calix; Richard J Porambo; Allison M Brady; Thomas R Larson; Janet Yother; Chitrananda Abeygunwardana; Moon H Nahm
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

Review 4.  Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.

Authors:  Hope L Johnson; Maria Deloria-Knoll; Orin S Levine; Sonia K Stoszek; Laura Freimanis Hance; Richard Reithinger; Larry R Muenz; Katherine L O'Brien
Journal:  PLoS Med       Date:  2010-10-05       Impact factor: 11.069

5.  Prevalence of nasopharyngeal pneumococcal colonization in children and antimicrobial susceptibility profiles of carriage isolates.

Authors:  Julie Y Zhou; Megan Isaacson-Schmid; Elizabeth C Utterson; Elizabeth M Todd; Michelle McFarland; Janardan Sivapalan; Joan M Niehoff; Carey-Ann D Burnham; S Celeste Morley
Journal:  Int J Infect Dis       Date:  2015-09-03       Impact factor: 3.623

Review 6.  Streptococcus pneumoniae colonisation: the key to pneumococcal disease.

Authors:  D Bogaert; R De Groot; P W M Hermans
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

Review 7.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Authors:  Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

8.  Nasopharyngeal Carriage, Antibiotic Resistance and Serotype Distribution of Streptococcus Pneumoniae among Healthy Adolescents in Zahedan.

Authors:  M Bokaeian; H A Khazaei; M Javadimehr
Journal:  Iran Red Crescent Med J       Date:  2011-05-01       Impact factor: 0.611

9.  Antimicrobial susceptibility and analysis of macrolide resistance genes in Streptococcus pneumoniae isolated in Hamadan.

Authors:  Mohammad Najafi Mosleh; Marzieh Gharibi; Mohammad Yousef Alikhani; Massoud Saidijam; Faezeh Vakhshiteh
Journal:  Iran J Basic Med Sci       Date:  2014-08       Impact factor: 2.699

10.  Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi.

Authors:  Stephen B Gordon; Stonard Kanyanda; Amanda L Walsh; Kirsty Goddard; Mas Chaponda; Victoria Atkinson; Wakisa Mulwafu; Elizabeth M Molyneux; Ed E Zijlstra; Malcolm E Molyneux; Steve M Graham
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more
  1 in total

1.  Prevalence and Multi-Drug Resistance of Streptococcus pneumoniae Infection Among Presumptive Tuberculosis Adult Cases at Dilla University Referral Hospital, Dilla, Ethiopia.

Authors:  Benyiam Kaloro Halala; Musa Mohammed Ali; Moges Desta Ormago
Journal:  Infect Drug Resist       Date:  2022-09-05       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.